Ann: Immutep receives FDA feedback for Efti development in MBC, page-10

Fully agree on the integrity point. Retail has stuck with IMM through thick and thin, many here are almost rusted on. So it’s not particularly inspiring or fair for retail to see consecutive runs and patterns form which strongly suggest sophs/tutes/third parties are always getting a head start with material information. Perception is important. IMM is now a bit like clockwork in this regard, and it would be good to see proactive internal management of this rather than dealing reactively to complaints or inquiries should they occur. The regulators are pretty toothless though, as @bluey10 noted.